SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Aug-24 6:36 PM View: | Spero Therapeutics, Inc. (SPRO) | 27-Aug-24 | Sale | 2,757 | $1.35 | $3,721.95 | (< 1%) 1.14M to 1.14M | |
06-Aug-24 7:56 PM View: | Spero Therapeutics, Inc. (SPRO) | 05-Aug-24 | Sale | 17,641 | $1.31 | $23,109.70 | (2%) 1.16M to 1.14M | |
06-Aug-24 7:56 PM View: | Spero Therapeutics, Inc. (SPRO) | 02-Aug-24 | Sale | 14,800 | $1.32 | $19,536.00 | (1%) 1.18M to 1.16M | |
05-Feb-24 8:40 PM View: | Spero Therapeutics, Inc. (SPRO) | 05-Feb-24 | Sale (Planned) | 45,093 | $1.45 | $65,384.90 | (4%) 1.22M to 1.18M | |
05-Feb-24 8:40 PM View: | Spero Therapeutics, Inc. (SPRO) | 02-Feb-24 | Sale | 30,901 | $1.37 | $42,334.40 | (2%) 1.25M to 1.22M | |
05-Feb-24 8:40 PM View: | Spero Therapeutics, Inc. (SPRO) | 01-Feb-24 | Grant | 679,501 | -- | -- | 119% 572.5K to 1.25M | |
30-Aug-23 4:20 PM View: | Spero Therapeutics, Inc. (SPRO) | 29-Aug-23 | Sale (Planned) | 4,163 | $1.30 | $5,411.90 | (< 1%) 576.66K to 572.5K | |
30-Aug-23 4:20 PM View: | Spero Therapeutics, Inc. (SPRO) | 28-Aug-23 | Sale | 1,854 | $1.26 | $2,336.04 | (< 1%) 578.52K to 576.66K | |
03-Aug-23 4:10 PM View: | Spero Therapeutics, Inc. (SPRO) | 01-Aug-23 | Grant | 266,000 | -- | -- | 85% 312.52K to 578.52K | |
03-Feb-23 7:41 PM View: | Spero Therapeutics, Inc. (SPRO) | 02-Feb-23 | Sale (Planned) | 9,504 | $1.83 | $17,372.40 | (3%) 322.02K to 312.52K | |
03-Feb-23 7:41 PM View: | Spero Therapeutics, Inc. (SPRO) | 01-Feb-23 | Grant | 265,957 | -- | -- | 474% 56.06K to 322.02K | |
30-Aug-22 5:00 PM View: | Spero Therapeutics, Inc. (SPRO) | 29-Aug-22 | Sale (Planned) | 6,017 | $0.89 | $5,377.99 | (10%) 62.08K to 56.06K | |
03-Feb-22 4:19 PM View: | Spero Therapeutics, Inc. (SPRO) | 01-Feb-22 | Grant | 38,014 | -- | -- | 158% 24.07K to 62.08K | |
30-Aug-21 4:15 PM View: | Spero Therapeutics, Inc. (SPRO) | 26-Aug-21 | Grant | 24,067 | -- | -- | 100% 0 to 24.07K | |
31-Jan-20 4:52 PM View: | ZIOPHARM Oncology, Inc. (TCRT) | 29-Jan-20 | Grant | 80,500 | -- | -- | 100% 0 to 80.5K |